Evidence map›Paper›PMID 34643781›Full record

Trial reportEuropean radiology2022

Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis.

Toru Tochigi, Sophia C Kamran, Anushri Parakh, Yoshifumi Noda, Balaji Ganeshan, Lawrence S Blaszkowsky, David P Ryan, Jill N Allen, David L Berger, Jennifer Y Wo and 2 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Toru TochigiDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Sophia C KamranDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Anushri ParakhDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Yoshifumi NodaDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Balaji GaneshanUniversity College London, London, UK.
Lawrence S BlaszkowskyDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.
David P RyanDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.
Jill N AllenDepartment of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.
David L BergerDepartment of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Jennifer Y WoDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Theodore S HongDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Avinash KambadakoneDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA. akambadakone@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-6714-9190
Massachusetts General Hospital · USChiba University · JPHarvard University · USUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere are individual variations in neo-adjuvant chemoradiation therapy (nCRT) in patients with locally advanced rectal cancer (LARC). No reliable modality currently exists that can predict the efficacy of nCRT. The purpose of this study is to assess if CT-based fractal dimension and filtration-histogram texture analysis can predict therapeutic response to nCRT in patients with LARC.

methodsIn this retrospective study, 215 patients (average age: 57 years (18-87 years)) who received nCRT for LARC between June 2005 and December 2016 and underwent a staging diagnostic portal venous phase CT were identified. The patients were randomly divided into two datasets: a training set (n = 170), and a validation set (n = 45). Tumor heterogeneity was assessed on the CT images using fractal dimension (FD) and filtration-histogram texture analysis. In the training set, the patients with pCR and non-pCR were compared in univariate analysis. Logistic regression analysis was applied to identify the predictive value of efficacy of nCRT and receiver operating characteristic analysis determined optimal cutoff value. Subsequently, the most significant parameter was assessed in the validation set.

resultsOut of the 215 patients evaluated, pCR was reached in 20.9% (n = 45/215) patients. In the training set, 7 out of 37 texture parameters showed significant difference comparing between the pCR and non-pCR groups and logistic multivariable regression analysis incorporating clinical and 7 texture parameters showed that only FD was associated with pCR (p = 0.001). The area under the curve of FD was 0.76. In the validation set, we applied FD for predicting pCR and sensitivity, specificity, and accuracy were 60%, 89%, and 82%, respectively.

conclusionFD on pretreatment CT is a promising parameter for predicting pCR to nCRT in patients with LARC and could be used to help make treatment decisions. KEY POINTS: • Fractal dimension analysis on pretreatment CT was associated with response to neo-adjuvant chemoradiation in patients with locally advanced rectal cancer. • Fractal dimension is a promising biomarker for predicting pCR to nCRT and may potentially select patients for individualized therapy.

Indexed as

Neoadjuvant TherapyRectal NeoplasmsChemoradiotherapyChemoradiotherapy, AdjuvantFractalsHumansMiddle AgedRetrospective StudiesTomography, X-Ray ComputedTreatment OutcomeBiomarkerCTNeoadjuvant chemoradiationRectal cancer

Identifiers

PMID34643781
OpenAlexW3206843396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.